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Canid herpesvirus 1 (CaHV-1) is a 
Varicellovirus of the subfamily 
Alphaherpesvirinae, family Herpesviridae, and 
order Herpesvirales, with a host range restricted 
to domestic and wild canids (Remond et al., 
1996). CaHV-1 was first recognized as the agent 
responsible for causing a highly fatal 
hemorrhagic viral disease in newborn puppies in 
1965. Apart from being an important disease in 
newborn puppies, CaHV-1 also affects 
reproduction of dogs in other ways: the virus 
may cause vesicular lesions in the vestibulum 
and vagina of the bitch, as well as on the penis 
and the preputial mucosa of dogs and may cause 
embryonic resorption, abortion, and fetal death 
(Carmichael, 1970). In addition, the virus is 
associated with respiratory (kennel cough 
syndrome) and ocular disease in dogs (Erles and 
Brownlie, 2005; Ledbetter et al., 2009). Oronasal 
and venereal transmission are the common routes 
of infection but transplacental infection has also 
been described. Lesions in the vestibulum and 
vagina of bitches may recur when bitches come 
into pro-estrus and regress when they go into 
anestrus (Carmichael, 1970; Hashimoto et al., 
1982). Affected animals may remain latent 
carriers and the virus was identified in the 
lumbosacral ganglia, tonsils, parotid salivary 
glands, and liver of dogs that showed no sign of 
herpesvirus infection (Burr et al., 1996). Several 
studies suggest that CaHV-1 is enzootic in the 
dog population. The disease was reported in 
numerous countries and the prevalence of 
antibodies (Abs) against CaHV-1 varies from 6% 
in some countries to higher than 90% in other 
(Ronsse et al., 2005; Nothling et al., 2008).
A first preliminary serological study performed 
in Argentina by a previously standardized 
enzyme linked immunosorbent analysis (ELISA) 
indicated a 23% of Abs prevalence (De Palma et 
al., 2006) In addition, typical clinical signs and 
neonatal mortality, suggesting viral activity, have 
been observed by Argentine breeders. This study 
reports an atypical clinical manifestation for 
CaHV-1 and the first viral isolation of this virus 
in Argentina.
A four-year-old privately owned female 
Labrador Retriever, which had been 
mastectomized two weeks before, presented 
vesicular lesions preceded by erythema in the 
internal part of the right thigh (Figure 1). 
Vesicles were surrounded by suppurative crusts 
and regional lymphoid nodes were enlarged. The 
lesions were first treated with local gentamicine 
(Kualcoderm, Kualcos - Buenos Aires, 
Argentina) for two days without improvement. 
Vesicular fluid was aspirated by a sterile syringe 
and transported in a refrigerated box to the 
laboratory of virology. In addition, blood 
samples for antibodies (Abs) detection were also
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drawn. Then, the lesions were treated with 5% 
acyclovir (ACV - Aciclovir Lafedar - Entre 
Rios, Argentina) cream three times daily for five 
days. A first rapid diagnosis was done by 
polymerase chain reaction (PCR) using specific 
oligonucleotide primers derived from the 
glycoprotein B gene of CaHV-1 (Pl: 5’ CAG 
GAC TAT TGG ACT ATA GT 3’, P2: 5’ TTG 
CAA TGC CCC TCA TAA TT 3’) (Burr et al., 
1996). The reaction was performed from a 
portion of boiled vesicular fluid and the DNA of 
the YP-11 Japanese strain (Dr. T. Mikami - 
Tokyo, Japan) was used as positive control. The 
conditions for PCR amplification were: a) 35 
cycles of 94°C for 30s, 57.5°C for lmin, 72°C 
for lmin; b) final extension at 72°C for 5min. 
The PCR products were examined on 3% 
agarose gel in TBE buffer (50mM Tris pH 8.0, 
50mM boric acid, and linM EDTA). The gels 
were examined under UV light following 
ethidium bromide staining. The molecular sizes 
of fragments were compared with those of a 
lOObp (base pairs) ladder (Promega Lab - 
Madison, USA). A visible band of weight equal 
to 120bp was considered a positive result. As a 
second step, the sample was diluted 1:10 in 
phosphate-buffered saline (PBS), centrifuged 
(3000g for 15min at 4°C) and inoculated over 
confluent monolayers cultures of Madin-Darby 
Canine Kidney (MDCK) cells grown in twenty- 
four-well plates. Plates were incubated at 35°C in 
an atmosphere of 5% CO2 and examined daily 
for the appearance of viral cytopathic effects 
(CPE). When CPE was extensive, the 
supernatant was separated by low speed 
centrifugation (3000g for 15min at 4°C) and 
titrated in MDCK cells using the Reed and 
Muench method. The titer was expressed at 96h 
post infection (pi) as CCID50 (cell culture 
infectious dose 50%)/50pL. In addition, infected 
and non-infected MDCK cells grown on 
coverslips were fixed for 30min in cold acetone 
for routine immunofluorescence analysis (IFA). 
To confirm the isolates as CaHV-1, serial two­
fold dilutions of dog anti-CaHV-1 reference 
serum were mixed with lOOCCIDso of the 
viruses isolated and after 60min of incubation in 
a 5% CO2 atmosphere, 100pL of MDCK cells 
(3* lO'cclls/mL) were added. For standard IF A, 
CaHV-1 monoclonal antibodies and anti mouse 
conjugated to fluorescein isothiocyanate (Zymed 
Laboratories - San Francisco, USA) were used 
as primary and secondary Abs, respectively. The 
Abs were determined by previously conventional 
standardized indirect ELISA test, using a soluble 
antigen produced with CaHV-1 YP-11 strain 
infected MDCK cells (De Palma et al., 2006).
The DNA was specifically amplified by PCR, 
generating a product that yielded a sharp visible 
band of 120bp on an ethidium bromide gel. 
Identical bands were obtained from positive 
controls. A focus of CPE consisting of spherical 
cells and lysis was detected on day 3 pi and then 
increased after successive passages (Figure 2). 
The IFA showed specific nuclear fluorescence 
(Figure 3). The isolated virus named LPJ 
(lO45CCID5lloo/5OpL) was confirmed as CaHV-1 
by the VN test. The ELISA test was also positive 
and indicated that a CaHV-1 infection was 
produced.
ACV is an antiviral agent with activity against a 
variety of viruses that has been found to be 
efficacious in the management of human herpes 
labialis in several formulations and routes of 
administration. In addition, ACV has been shown 
to have an effect on veterinary herpesvirus 
(Asano, 1995; Garre et al., 2007). In the case 
reported in this work, it was observed that the 
lesions decreased rapidly from day 2 of ACV 
treatment. The exact explanation of this unusual 
CaHV-1 clinical presentation is not known. In 
this particular case, no other previous clinical 
signs were observed. As in other 
alphaherpesviruses, the CaHV-1 latency in 
sensory ganglia has been reported (Miyoshi et 
al., 1999). ft is also known that latent viruses in 
the lumbosacral nodes have an important role in 
venereal infections (Burr et al., 1996). A possible 
explanation is that the virus had replicated in the 
epithelial cells of the vagina (self-limited 
primary infection), established latency, and then 
was reactivated by the post surgical immune 
depression, producing the skin lesions described. 
The PCR, VI, and IFA confirmed that the lesions 
were produced by CaHV-1.
To the authors' knowledge, the occurrence of 
vesicular lesions produced by CaHV in the area 
described was never reported. This is not only 
the first report of an atypical localization for to 
consider in the future, but also the first isolation 
of this virus in Argentina.
Keywords: dog. Canid herpesvirus 7, atypical 
clinical lesions, viral isolation
1268 Arq. Bras. Med. Vet Zootec., v.62, n.5, p.1267-1270, 2010
An atypical clinical..
Figure 1. Skin lesions of a four-year-old female Labrador Retriever. Image shows vesicles surrounded by 
erythema.
Figure 2. MDCK control cells (A) and cytophatic changes (B) observed at 3 days post infection over 
MDCK cells inoculated with liquid of skin lesions of a four-year-old female Labrador Retriever. (Obj. 
10X and 20X. respectively).
Figure 3. Immunofluorescence analysis over MDCK cells inoculated with the isolated virus. Images show 
negative controls cells (A) and specific positive nuclear fluorescence (B) (Obj. 25X).
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RESUMO
Relatam-se o primeiro isolamento de herpesvirus canino 1 (CaHV-1) e a localizacào atipica das lesòes 
vesiculares associadas a este virus na Argentina. A amostra fai recuperada de lesòes vesiculares, 
localizadas na parte interna da coxa direita, em urna fèmea de raca Labrador. A cadela tinha quatro 
anos de idade e era de propriedade privada. O primeiro diagnòstico foi realizado pela re accio em cadeia 
da polimerase e, posteriormente, o virus fai isolado e sua idenlificaccìo confirmada por 
imunofluorescència indireta e pelo teste de neutralizando virai.
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